We’re elated to share that the first paper from our lab has recently been accepted into iScience (Danielson et al., 2024). We’ve discovered mechanisms by which bacteria activate innate immunity in tumors, and are leveraging this knowledge to use small molecule STING+TLR agonists for synergistic anti-tumor responses. Be on the lookout for it coming in print form!
Lab’s first paper accepted!
on